Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Moran Zur

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|November 23, 2013
The complexity of intestinal permeability: Assigning the correct BCS classification through careful data interpretationMoran Zur, Allison S Hanson, Arik Dahan
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|July 3, 2020
Biopharmaceutical characterization of rebamipide: The role of mucus binding in regional-dependent intestinal permeabilityMilica Markovic, Moran Zur, Arik Dahan, et al.
International Journal of Pharmaceutics|May 11, 2015
The biopharmaceutics of successful controlled release drug product: Segmental-dependent permeability of glipizide vs. metoprolol throughout the intestinal tractMoran Zur, Noa Cohen, Riad Agbaria, et al.
Pharmaceutics|December 5, 2020
BCS Class IV Oral Drugs and Absorption Windows: Regional-Dependent Intestinal Permeability of FurosemideMilica Markovic, Moran Zur, Inna Ragatsky, et al.
Molecular Pharmaceutics|April 17, 2014
The low/high BCS permeability class boundary: physicochemical comparison of metoprolol and labetalolMoran Zur, Marisa Gasparini, Omri Wolk, et al.
Molecular Pharmaceutics|November 26, 2014
Intestinal permeability study of minoxidil: assessment of minoxidil as a high permeability reference drug for biopharmaceutics classificationMakoto Ozawa, Yasuhiro Tsume, Moran Zur, et al.
Pharmaceutics|November 27, 2021
Optimized In Silico Modeling of Drug Absorption after Gastric Bypass: The Case of MetforminArik Dahan, Daniel Porat, Milica Markovic, et al.
Molecular Pharmaceutics|May 16, 2017
Toward Successful Cyclodextrin Based Solubility-Enabling Formulations for Oral Delivery of Lipophilic Drugs: Solubility-Permeability Trade-Off, Biorelevant Dissolution, and the Unstirred Water LayerNoa Fine-Shamir, Avital Beig, Moran Zur, et al.
Pharmaceutics|March 28, 2020
Segmental-Dependent Solubility and Permeability as Key Factors Guiding Controlled Release Drug Product DevelopmentMilica Markovic, Moran Zur, Noa Fine-Shamir, et al.
Pharmaceutics|July 27, 2022
The Role of Paracellular Transport in the Intestinal Absorption and Biopharmaceutical Characterization of MinoxidilMilica Markovic, Moran Zur, Sapir Garsiani, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|November 23, 2013
The complexity of intestinal permeability: Assigning the correct BCS classification through careful data interpretationMoran Zur, Allison S Hanson, Arik Dahan
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|July 3, 2020
Biopharmaceutical characterization of rebamipide: The role of mucus binding in regional-dependent intestinal permeabilityMilica Markovic, Moran Zur, Arik Dahan, et al.
International Journal of Pharmaceutics|May 11, 2015
The biopharmaceutics of successful controlled release drug product: Segmental-dependent permeability of glipizide vs. metoprolol throughout the intestinal tractMoran Zur, Noa Cohen, Riad Agbaria, et al.
Pharmaceutics|December 5, 2020
BCS Class IV Oral Drugs and Absorption Windows: Regional-Dependent Intestinal Permeability of FurosemideMilica Markovic, Moran Zur, Inna Ragatsky, et al.
Molecular Pharmaceutics|April 17, 2014
The low/high BCS permeability class boundary: physicochemical comparison of metoprolol and labetalolMoran Zur, Marisa Gasparini, Omri Wolk, et al.
Molecular Pharmaceutics|November 26, 2014
Intestinal permeability study of minoxidil: assessment of minoxidil as a high permeability reference drug for biopharmaceutics classificationMakoto Ozawa, Yasuhiro Tsume, Moran Zur, et al.
Pharmaceutics|November 27, 2021
Optimized In Silico Modeling of Drug Absorption after Gastric Bypass: The Case of MetforminArik Dahan, Daniel Porat, Milica Markovic, et al.
Molecular Pharmaceutics|May 16, 2017
Toward Successful Cyclodextrin Based Solubility-Enabling Formulations for Oral Delivery of Lipophilic Drugs: Solubility-Permeability Trade-Off, Biorelevant Dissolution, and the Unstirred Water LayerNoa Fine-Shamir, Avital Beig, Moran Zur, et al.
Pharmaceutics|March 28, 2020
Segmental-Dependent Solubility and Permeability as Key Factors Guiding Controlled Release Drug Product DevelopmentMilica Markovic, Moran Zur, Noa Fine-Shamir, et al.
Pharmaceutics|July 27, 2022
The Role of Paracellular Transport in the Intestinal Absorption and Biopharmaceutical Characterization of MinoxidilMilica Markovic, Moran Zur, Sapir Garsiani, et al.
Pageof 2